VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_19-vv-00607
Package ID: USCOURTS-cofc-1_19-vv-00607
Petitioner: Kenneth Barber
Filed: 2019-04-24
Decided: 2021-05-25
Vaccine: Tdap
Vaccination date: 2018-02-21
Condition: Guillain-Barré syndrome
Outcome: compensated
Award amount USD: 62500

AI-assisted case summary:
On April 24, 2019, Kenneth Barber filed a petition for compensation alleging that the tetanus-diphtheria-acellular pertussis (Tdap) and pneumococcal conjugate (PCV) vaccines he received on February 21, 2018, caused him to suffer Guillain-Barré syndrome (GBS) and its residual effects for more than six months. The vaccines are listed on the Vaccine Injury Table. The respondent denied that the vaccines caused Mr. Barber's GBS or any other injury. However, the parties filed a joint stipulation agreeing to compensation. Special Master Christian J. Moran reviewed the stipulation and adopted it as the decision of the Court. The stipulation awarded Mr. Barber a lump sum payment of $62,500.00, payable by check to the petitioner, as compensation for all damages. The decision was filed on May 25, 2021. Petitioner counsel was Diana L. Stadelnikas of Maglio Christopher and Toale, PA, and respondent counsel was Jennifer L. Reynaud of the United States Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, or expert testimony.

Theory of causation field:
Petitioner Kenneth Barber alleged that the Tdap and PCV vaccines received on February 21, 2018, caused Guillain-Barré syndrome (GBS) and residual effects lasting over six months. The vaccines are listed on the Vaccine Injury Table. Respondent denied causation. The parties filed a joint stipulation for compensation, which Special Master Christian J. Moran adopted. The stipulation resulted in a lump sum award of $62,500.00. The public decision does not detail the specific mechanism of injury, expert testimony, or clinical findings. Petitioner counsel was Diana L. Stadelnikas and respondent counsel was Jennifer L. Reynaud. The decision date was May 25, 2021.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_19-vv-00607-0
Date issued/filed: 2021-06-10
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 5/25/2021) regarding 50 DECISION Stipulation/Proffer. Signed by Special Master Christian J. Moran. (Attachments: # (1) Appendix Joint Stipulation) (jmw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:19-vv-00607-UNJ Document 53 Filed 06/10/21 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
* * * * * * * * * * * * * * * * * * * * *
KENNETH BARBER, *
* No. 19-607V
Petitioner, * Special Master Christian J. Moran
*
v. * Filed: May 25, 2021
*
SECRETARY OF HEALTH * Stipulation; Tetanus Diphtheria
AND HUMAN SERVICES, * acellular pertussis (“Tdap”) vaccine;
* pneumococcal conjugate (“PCV”)
* vaccine; Guillain-Barré Syndrome
Respondent. * (“GBS”).
* * * * * * * * * * * * * * * * * * * * *
Diana L. Stadelnikas, Maglio Christopher and Toale, PA, Sarasota, FL, for
Petitioner;
Jennifer L. Reynaud, United States Dep’t of Justice, Washington, DC, for
Respondent.
UNPUBLISHED DECISION1
On May 24, 2021, the parties filed a joint stipulation concerning the petition
for compensation filed by Kenneth Barber on April 24, 2019. Petitioner alleged
that the tetanus-diphtheria-acellular pertussis (“Tdap”) and pneumococcal
conjugate (PCV”) vaccines he received on February 21, 2018, which are contained
in the Vaccine Injury Table (the “Table”), 42 C.F.R. §100.3(a), caused him to
suffer Guillain-Barré syndrome. Petitioner further alleges that he suffered the
residual effects of this injury for more than six months. Petitioner represents that
there has been no prior award or settlement of a civil action for damages on his
behalf as a result of his condition.
1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and
Promotion of Electronic Government Services), requires that the Court post this decision on its
website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing
redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4).
Any redactions ordered by the special master will appear in the document posted on the website.

Case 1:19-vv-00607-UNJ Document 53 Filed 06/10/21 Page 2 of 2
Respondent denies that petitioner’s alleged GBS and residual effects were
caused-in-fact by the Tdap or PCV vaccine; and denies that the Tdap and/or PCV
vaccine caused petitioner any other injury or his current condition.
Nevertheless, the parties agree to the joint stipulation, attached hereto. The
undersigned finds said stipulation reasonable and adopts it as the decision of the
Court in awarding damages, on the terms set forth therein.
Damages awarded in that stipulation include:
A lump sum payment of $62,500.00 in the form of a check payable to
petitioner. This amount represents compensation for all damages that
would be available under 42 U.S.C. § 300aa-15(a).
In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment according to this decision and the attached
stipulation.2
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
Special Master
2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
2